These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9118461

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Simple and sensitive high performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of topotecan in human plasma.
    Vali AM, Shafaghi B, Dadashzadeh S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr 25; 818(2):205-12. PubMed ID: 15734160
    [Abstract] [Full Text] [Related]

  • 43. Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive high-performance liquid chromatography with fluorescence detection.
    Loos WJ, Sparreboom A, Verweij J, Nooter K, Stoter G, Schellens JH.
    J Chromatogr B Biomed Sci Appl; 1997 Jul 04; 694(2):435-41. PubMed ID: 9252060
    [Abstract] [Full Text] [Related]

  • 44. Determination of topotecan by ELISA.
    Saita T, Fujito H, Mori M.
    Biol Pharm Bull; 2001 Apr 04; 24(4):321-6. PubMed ID: 11305588
    [Abstract] [Full Text] [Related]

  • 45. Intrathecal administration of topotecan in nonhuman primates.
    Blaney SM, Cole DE, Godwin K, Sung C, Poplack DG, Balis FM.
    Cancer Chemother Pharmacol; 1995 Apr 04; 36(2):121-4. PubMed ID: 7767947
    [Abstract] [Full Text] [Related]

  • 46. Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of carboxylate and lactone forms of 14 new camptothecin derivatives.
    Sano K, Yoshikawa M, Hayasaka S, Satake K, Ikegami Y, Yoshida H, Ishikawa T, Sawada S, Tanabe S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep 25; 795(1):25-34. PubMed ID: 12957166
    [Abstract] [Full Text] [Related]

  • 47. Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan.
    Akhtar S, Beckman RA, Mould DR, Doyle E, Fields SZ, Wright J.
    Cancer Chemother Pharmacol; 2000 Sep 25; 46(3):204-10. PubMed ID: 11021737
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. High-performance liquid chromatographic assay for the determination of total and free topotecan in the presence and absence of anti-topotecan antibodies in mouse plasma.
    Chen J, Balthasar JP.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb 25; 816(1-2):183-92. PubMed ID: 15664349
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors.
    Rodriguez-Galindo C, Crews KR, Stewart CF, Furman W, Panetta JC, Daw NC, Cain A, Tan M, Houghton PH, Santana VM.
    Cancer Chemother Pharmacol; 2006 Jan 25; 57(1):15-24. PubMed ID: 16001174
    [Abstract] [Full Text] [Related]

  • 55. Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors.
    Zamboni WC, Bowman LC, Tan M, Santana VM, Houghton PJ, Meyer WH, Pratt CB, Heideman RL, Gajjar AJ, Pappo AS, Stewart CF.
    Cancer Chemother Pharmacol; 1999 Jan 25; 43(6):454-60. PubMed ID: 10321504
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Pharmacokinetics of SK & F 104864 in experimental animals. I. Plasma level].
    Fujita H, Okamoto M, Takao A, Abe H, Ishii R, Takeda K.
    Gan To Kagaku Ryoho; 1995 Oct 25; 22(12):1783-7. PubMed ID: 7574810
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Development and validation of a reverse-phase HPLC with fluorescence detector method for simultaneous determination of CZ48 and its active metabolite camptothecin in mouse plasma.
    Liu X, Wang Y, Vardeman D, Cao Z, Giovanella B.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May 01; 867(1):84-9. PubMed ID: 18396471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.